Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
5.14
-0.05 (-0.96%)
At close: Jul 6, 2026, 4:00 PM EDT
5.15
+0.01 (0.19%)
After-hours: Jul 6, 2026, 7:32 PM EDT
Immuneering Market Cap
Immuneering has a market cap or net worth of $332.54 million as of July 6, 2026. Its market cap has increased by 233.61% in one year.
Market Cap
332.54M
Enterprise Value
137.63M
1-Year Change
233.61%
Ranking
Category
Stock Price
$5.14
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $332.54M, a decrease of -9.10%. That is a compound annual growth rate of -1.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 332.54M | -21.73% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | 365.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OmniAb | 350.83M |
| Opus Genetics | 344.30M |
| Indaptus Therapeutics | 343.12M |
| Fate Therapeutics | 340.35M |
| Larimar Therapeutics | 340.29M |
| Inhibikase Therapeutics | 339.14M |
| Lineage Cell Therapeutics | 336.55M |
| InflaRx | 329.94M |